Ayala Pharmaceuticals, Inc.

Ayala Pharmaceuticals, Inc. (AYLA), relating to its proposed merger with Advaxis, Inc. Under the terms of the agreement, AYLA shareholders are expected to own approximately 62.5% of the combined company.

To receive more information regarding the investigation of Ayala Pharmaceuticals, Inc. please fill out the form below.